-
The Lundquist Institute Receives $3 Million From NIH to Expand Male Contraceptive Study
The Lundquist Institute’s Male Contraceptive Efficacy Trial has received an additional $3 million from the National Institutes of Health (NIH) to expand its work and recruit…
Research -
The Lundquist Institute Receives Prestigious CIRM Scholar Research Training Award
The CIRM Grant Will Support Stem Cell Training and Research for the Institute’s PhD Students, Postdoctoral Fellows and Clinical Fellows
Education, Research -
Lundquist Institute Investigators Find That Early Administration of Convalescent Plasma Does Not Prevent COVID-19 Disease Progression
Convalescent plasma from blood donors who have recovered from COVID-19 does not prevent disease in acutely ill, high-risk patients with COVID-19.
Research -
BioLabs LA at The Lundquist Institute Reaches 100% Capacity
LOS ANGELES — BioLabs LA at The Lundquist Institute, a co-working and incubator facility for high-potential bioscience start-ups, has reached 100% capacity ahead of schedule. This…
Research -
Lundquist Institute Investigators Contribute to Global Study Expanding Genomic Research Into Different Ancestries
Paper in Nature Genetics: Genome-wide Meta-Analysis Shows That Research into Different Ancestries Leads to Better Results and Better Care
Research -
Lundquist Institute Investigator Wei Yan, MD, PhD, Solves Longstanding Fallopian Tube Transport Debate
Yan Group’s Research Shows That Motile Cilia Are Key to Oocyte Pickup in the Fallopian Tube
Research -
Lundquist Institute Investigator Ashraf Ibrahim, PhD, Leads Life-Saving Research on Mucormycosis, the Deadly “Black Fungus”
Dr. Ibrahim’s start-up Vitalex Biosciences is manufacturing humanized monoclonal antibodies that would stem the spread of this fatal disease
Research -
The Lundquist Institute Spearheads Life-Saving COVID-19 Clinical Research Trials in Rapid Response to the Pandemic
COVID Research Supports The Institute’s Core Mission to Save Lives and Empower Healthcare Equity
Community, Research -
Lundquist Institute Investigator Matt Budoff, Md, Presents Further Analyses Showing Icosapent Ethyl Significantly Reduces Coronary Plaque
Matthew Budoff, MD, Will Present the Analyses at the European Society of Cardiology (ESC) Preventive Cardiology 2021
Research -
The Lundquist Institute Investigator Dong Chang’s Study on Nonbeneficial ICU Treatment Published in JAMA Internal Medicine
For Critically Ill Patients with Advanced Medical Illnesses and Poor Prognoses, Overuse of Invasive ICU Treatment May Prolong Suffering
Research